These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 32516571)

  • 1. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
    Jiang RD; Liu MQ; Chen Y; Shan C; Zhou YW; Shen XR; Li Q; Zhang L; Zhu Y; Si HR; Wang Q; Min J; Wang X; Zhang W; Li B; Zhang HJ; Baric RS; Zhou P; Yang XL; Shi ZL
    Cell; 2020 Jul; 182(1):50-58.e8. PubMed ID: 32516571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
    Sun SH; Chen Q; Gu HJ; Yang G; Wang YX; Huang XY; Liu SS; Zhang NN; Li XF; Xiong R; Guo Y; Deng YQ; Huang WJ; Liu Q; Liu QM; Shen YL; Zhou Y; Yang X; Zhao TY; Fan CF; Zhou YS; Qin CF; Wang YC
    Cell Host Microbe; 2020 Jul; 28(1):124-133.e4. PubMed ID: 32485164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
    Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
    Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
    Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
    Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
    Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
    Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.
    Lutz C; Maher L; Lee C; Kang W
    Hum Genomics; 2020 Jun; 14(1):20. PubMed ID: 32498696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
    Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
    Israelow B; Song E; Mao T; Lu P; Meir A; Liu F; Alfajaro MM; Wei J; Dong H; Homer RJ; Ring A; Wilen CB; Iwasaki A
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32750141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
    Sun J; Zhuang Z; Zheng J; Li K; Wong RL; Liu D; Huang J; He J; Zhu A; Zhao J; Li X; Xi Y; Chen R; Alshukairi AN; Chen Z; Zhang Z; Chen C; Huang X; Li F; Lai X; Chen D; Wen L; Zhuo J; Zhang Y; Wang Y; Huang S; Dai J; Shi Y; Zheng K; Leidinger MR; Chen J; Li Y; Zhong N; Meyerholz DK; McCray PB; Perlman S; Zhao J
    Cell; 2020 Aug; 182(3):734-743.e5. PubMed ID: 32643603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of K18-
    Moreau GB; Burgess SL; Sturek JM; Donlan AN; Petri WA; Mann BJ
    Am J Trop Med Hyg; 2020 Sep; 103(3):1215-1219. PubMed ID: 32723427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
    Hassan AO; Case JB; Winkler ES; Thackray LB; Kafai NM; Bailey AL; McCune BT; Fox JM; Chen RE; Alsoussi WB; Turner JS; Schmitz AJ; Lei T; Shrihari S; Keeler SP; Fremont DH; Greco S; McCray PB; Perlman S; Holtzman MJ; Ellebedy AH; Diamond MS
    Cell; 2020 Aug; 182(3):744-753.e4. PubMed ID: 32553273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional modelling of SARS-CoV-2 entry in animal models.
    Brooke GN; Prischi F
    Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles.
    Zhang YN; Li XD; Zhang ZR; Zhang HQ; Li N; Liu J; Li JQ; Zhang HJ; Wang ZJ; Shen S; Shi ZL; Wei HP; Yuan ZM; Ye HQ; Zhang B
    Cell Res; 2020 Nov; 30(11):1046-1048. PubMed ID: 32843719
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.
    Drelich AK; Rayavara K; Hsu J; Saenkham-Huntsinger P; Judy BM; Tat V; Ksiazek TG; Peng BH; Tseng CK
    PLoS Pathog; 2024 Jun; 20(6):e1011777. PubMed ID: 38913740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.